Back to search
FDAFDA · Food and drugs·Recall number D-0529-2025

Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90

Published July 9, 2025 · Recall initiated: June 26, 2025

Summary

FDA records drug Class III recall D-0529-2025, published July 9, 2025 and initiated June 26, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 8,573 bottles; Lot: Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if PITAVASTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PITAVASTATIN
Manufacturer
AvKARE
Distributor
Nationwide in the USA
Lot
Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90 recalled?

Yes. FDA published recall D-0529-2025 on July 9, 2025. Reported hazard: Failed Impurity/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PITAVASTATIN.